Guangzhou Magpie Pharmaceuticals Co., Ltd.
Address: No.3XXXXXXXXXXXX
China (Mainland)
State of ownership: PrXXXXXXXXXXXXXXXXXXX
Headquarters: HQ:XXXX
Company main phone: 83XXXXXX
Email: mengXXXXXXXXXXXXXXXXXXXXXXXX
Website: httpXXXXXXXXXXXXXXXXXXXXXXXXX
GuanXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
| Distribution: |
|
| Phase I: | 1 | |
| Phase II: | 3 |
The company has more than a dozen of innovative drugs in the development pipelines. In the coming three years, it endeavors to obtain 4 to 6 Chinese clinical research documents and 1 or 2 US or European clinical research documents.
Biotechgate Business Development and Licensing Database
Biotechgate is the global lead sourcing database for the Biotech, Pharma and Medtech industries.
Biotechgate Digital Partnering
Biotechgate Digital Partnering is designed to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies.
Biotechgate Global Database ›




